✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Neuland Laboratories Ltd.

NEULANDLAB

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹20,133 Cr.
P/E
114.31

Neuland Laboratories Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
20,133 Cr
PE
PE
114
Prom Holding
Prom Holding
32.68 %
ROE (%)
ROE (%)
17.06
ROCE (%)
ROCE (%)
16.23
Div Yield (%)
Div Yield (%)
0.08
Sales
Sales
1,329 Cr
OPM (%)
OPM (%)
17.62 %
Debt to Equity
Debt to Equity
0.09
View more
Edit Ratio's

About

Neuland Laboratories is a prominent manufacturer of active pharmaceutical ingredients (APIs) a… Read more
Low
10191
52W Range
High
18100
  • Neuland Laboratories
  • Gufic Biosciences
  • Alivus Life Sciences
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New
Edit rows

Forensics

11 Yes

Positive for this company

2 Neutral

Neutral for this company

4 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up - Custom Manufacturing Solutions(CMS)

Product Wise Break-Up

Location Wise Break-Up

Therapeutic Area Break-Up

Asset Break-Up

Operational Metrics

    locked
    Select a Metric
    • US DMF Filings (.)
      Source
    • Global DMFs filed (.)
      Source
    • Total reactor capacity (kL)
      Source
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    Suppliers

    • Bodhtree Consulting Ltd.

    Customers

    • Aurobindo Pharma Ltd.
    • Dr. Reddy's Laboratories Ltd.
    • Lupin Ltd.
    • Novartis India Ltd.
    • Amneal Pharmaceuticals

    FAQs on Neuland Laboratories Ltd. Business

    Neuland Laboratories specializes in manufacturing APIs and providing comprehensive solutions for drug development and cGMP manufacturing in the pharmaceutical industry.

    Neuland Laboratories major competitors are Gufic Biosciences, Alivus Life Sciences, Granules India, Acutaas Chemicals, Aarti Pharmalabs, Shilpa Medicare, Supriya Lifescience.
    Market Cap of Neuland Laboratories is ₹20,133 Crs.
    While the median market cap of its peers are ₹8,311 Crs.

    Neuland Laboratories seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    View FAQ's On Shareprice

    Company Filing

    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release May Jul Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Mar Jun Sep Dec Mar Sep Dec
    Investor Presentation May Jul Mar Jun Sep Dec Mar Jun Sep Dec Feb Mar Jun Aug Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Sep Dec Mar Sep Dec Mar Sep Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Dec
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Neuland Laboratories Ltd.
    Neuland Labs Business Analysis| - Reaching Critical Mass - SOIC
    What Are Peptides? - SOIC
    Neuland Lab - Story Of Transformation - Sahil Sharma
    Neuland Labs - Detailed Analysis with Speciality APIs - Value Educator
    View the discussion on ValuePickr
    Why Neuland Is A Solid Business - UnseenValue
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material